BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 35033854)

  • 1. Endothelial thrombomodulin downregulation caused by hypoxia contributes to severe infiltration and coagulopathy in COVID-19 patient lungs.
    Won T; Wood MK; Hughes DM; Talor MV; Ma Z; Schneider J; Skinner JT; Asady B; Goerlich E; Halushka MK; Hays AG; Kim DH; Parikh CR; Rosenberg AZ; Coppens I; Johns RA; Gilotra NA; Hooper JE; Pekosz A; Čiháková D
    EBioMedicine; 2022 Jan; 75():103812. PubMed ID: 35033854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study.
    Goshua G; Pine AB; Meizlish ML; Chang CH; Zhang H; Bahel P; Baluha A; Bar N; Bona RD; Burns AJ; Dela Cruz CS; Dumont A; Halene S; Hwa J; Koff J; Menninger H; Neparidze N; Price C; Siner JM; Tormey C; Rinder HM; Chun HJ; Lee AI
    Lancet Haematol; 2020 Aug; 7(8):e575-e582. PubMed ID: 32619411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of pulmonary tissue factor, loss of thrombomodulin and immunothrombosis in SARS-CoV-2 infection.
    Francischetti IMB; Toomer K; Zhang Y; Jani J; Siddiqui Z; Brotman DJ; Hooper JE; Kickler TS
    EClinicalMedicine; 2021 Sep; 39():101069. PubMed ID: 34377969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 Spike Proteins and Cell-Cell Communication Inhibits TFPI and Induces Thrombogenic Factors in Human Lung Microvascular Endothelial Cells and Neutrophils: Implications for COVID-19 Coagulopathy Pathogenesis.
    Bhargavan B; Kanmogne GD
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 Spike Proteins and Cell-Cell Communication Induce P-Selectin and Markers of Endothelial Injury, NETosis, and Inflammation in Human Lung Microvascular Endothelial Cells and Neutrophils: Implications for the Pathogenesis of COVID-19 Coagulopathy.
    Bhargavan B; Kanmogne GD
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung Epithelial Cell Transcriptional Regulation as a Factor in COVID-19-associated Coagulopathies.
    FitzGerald ES; Chen Y; Fitzgerald KA; Jamieson AM
    Am J Respir Cell Mol Biol; 2021 Jun; 64(6):687-697. PubMed ID: 33740387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelium Infection and Dysregulation by SARS-CoV-2: Evidence and Caveats in COVID-19.
    Bernard I; Limonta D; Mahal LK; Hobman TC
    Viruses; 2020 Dec; 13(1):. PubMed ID: 33375371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronavirus Disease 2019 (COVID-19) Coronary Vascular Thrombosis: Correlation with Neutrophil but Not Endothelial Activation.
    Johnson JE; McGuone D; Xu ML; Jane-Wit D; Mitchell RN; Libby P; Pober JS
    Am J Pathol; 2022 Jan; 192(1):112-120. PubMed ID: 34599881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19.
    Ackermann M; Verleden SE; Kuehnel M; Haverich A; Welte T; Laenger F; Vanstapel A; Werlein C; Stark H; Tzankov A; Li WW; Li VW; Mentzer SJ; Jonigk D
    N Engl J Med; 2020 Jul; 383(2):120-128. PubMed ID: 32437596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers of endothelial dysfunction and outcomes in coronavirus disease 2019 (COVID-19) patients: A systematic review and meta-analysis.
    Andrianto ; Al-Farabi MJ; Nugraha RA; Marsudi BA; Azmi Y
    Microvasc Res; 2021 Nov; 138():104224. PubMed ID: 34273359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial dysfunction contributes to COVID-19-associated vascular inflammation and coagulopathy.
    Zhang J; Tecson KM; McCullough PA
    Rev Cardiovasc Med; 2020 Sep; 21(3):315-319. PubMed ID: 33070537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local Complement Contributes to Pathogenic Activation of Lung Endothelial Cells in SARS-CoV-2 Infection.
    Zhang H; Gerasimovskaya E; McCarthy MK; May NA; Prasad RR; Riddle S; McKeon BA; Kumar S; Li M; Hu CJ; Frid MG; Morrison TE; Stenmark KR
    Am J Respir Cell Mol Biol; 2023 Aug; 69(2):210-219. PubMed ID: 37071849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 Spike Protein Destabilizes Microvascular Homeostasis.
    Panigrahi S; Goswami T; Ferrari B; Antonelli CJ; Bazdar DA; Gilmore H; Freeman ML; Lederman MM; Sieg SF
    Microbiol Spectr; 2021 Dec; 9(3):e0073521. PubMed ID: 34935423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial cell dysfunction, coagulation, and angiogenesis in coronavirus disease 2019 (COVID-19).
    Norooznezhad AH; Mansouri K
    Microvasc Res; 2021 Sep; 137():104188. PubMed ID: 34022205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial cell infection and dysfunction, immune activation in severe COVID-19.
    Qin Z; Liu F; Blair R; Wang C; Yang H; Mudd J; Currey JM; Iwanaga N; He J; Mi R; Han K; Midkiff CC; Alam MA; Aktas BH; Heide RSV; Veazey R; Piedimonte G; Maness NJ; Ergün S; Mauvais-Jarvis F; Rappaport J; Kolls JK; Qin X
    Theranostics; 2021; 11(16):8076-8091. PubMed ID: 34335981
    [No Abstract]   [Full Text] [Related]  

  • 16. Thromboplasminflammation in COVID-19 Coagulopathy: Three Viewpoints for Diagnostic and Therapeutic Strategies.
    Gando S; Wada T
    Front Immunol; 2021; 12():649122. PubMed ID: 34177896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prothrombotic Phenotype in COVID-19: Focus on Platelets.
    Barale C; Melchionda E; Morotti A; Russo I
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects.
    Smadja DM; Mentzer SJ; Fontenay M; Laffan MA; Ackermann M; Helms J; Jonigk D; Chocron R; Pier GB; Gendron N; Pons S; Diehl JL; Margadant C; Guerin C; Huijbers EJM; Philippe A; Chapuis N; Nowak-Sliwinska P; Karagiannidis C; Sanchez O; Kümpers P; Skurnik D; Randi AM; Griffioen AW
    Angiogenesis; 2021 Nov; 24(4):755-788. PubMed ID: 34184164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin prevents in vitro glycocalyx shedding induced by plasma from COVID-19 patients.
    Potje SR; Costa TJ; Fraga-Silva TFC; Martins RB; Benatti MN; Almado CEL; de Sá KSG; Bonato VLD; Arruda E; Louzada-Junior P; Oliveira RDR; Zamboni DS; Becari C; Auxiliadora-Martins M; Tostes RC
    Life Sci; 2021 Jul; 276():119376. PubMed ID: 33781826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 coagulopathy - what should we treat?
    Chowdary P
    Exp Physiol; 2022 Jul; 107(7):749-758. PubMed ID: 35733235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.